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[Abstract] 15 
Trypanosomatid parasites cause diseases in humans and livestock. It was reported that 16 
partial inhibition of the vacuolar ATPase (V-ATPase) affects dependence of Trypanosoma 17 
brucei on its mitochondrial genome (kDNA), a target of the anti-trypanosomatid drug 18 
isometamidium. Here we report that V-ATPase inhibition with bafilomycin A1 (BafA) 19 
provides partial resistance to genetic knockdown of mitochondrial gene expression. BafA 20 
does not promote long-term survival after kDNA loss, but in its presence, isometamidium 21 
causes less damage to kDNA. 22 
 23 
 24 
Trypanosomatid parasites cause a range of debilitating or fatal diseases in humans and 25 
animals, typically transmitted by insect vectors (1, 2). Important diseases include Chagas 26 
disease, caused by Trypanosoma cruzi, various forms of leishmaniasis, caused by 27 
Leishmania spp, Human African Trypanosomiasis (also known as sleeping sickness), 28 
caused by T. brucei subspecies T. b. gambiense and T. b. rhodesiense, and the livestock 29 
disease nagana, caused by T. vivax, T. congolense and, less frequently, T. b. brucei. 30 
 31 
Trypanosomatids belong to the clade Kinetoplastea, flagellated protists characterised by 32 
their unusual mitochondrial DNA, called the kinetoplast or kDNA. T. brucei kDNA is a 33 
concatenated network of dozens of 23-kb maxicircles (the equivalent of mitochondrial DNA 34 
in other eukaryotes) and thousands of ~1-kb minicircles that encode guide RNAs (gRNAs). 35 
The latter ‘guide’ post-transcriptional editing of most maxicircle-encoded mRNAs, a 36 
process that is essential for generating functional transcripts (3–5). Maintenance and 37 
expression of kDNA are essential in both the mammalian bloodstream form (BF) and the 38 
insect stage of T. brucei (3), and interference with kDNA maintenance is involved in the 39 
mode of action of anti-trypanosomatid drugs such as ethidium bromide (EtBr) and 40 
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isometamidium chloride (ISM) (6–8). However, BF T. brucei appear to require only a single 41 
mitochondrial gene product for survival, subunit a of the FO moiety of the F1FO-ATP 42 
synthase (although translation of the subunit a mRNA requires another kDNA-encoded 43 
protein, subunit RPS12 of the mitochondrial ribosome). In that stage of the life cycle this 44 
complex operates in reverse, as an ATP-driven proton pump, to generate the mitochondrial 45 
membrane potential (9–11). Mutations in the nuclearly encoded γ subunit of the ATP 46 
synthase, such as L262P, can fully compensate for loss of kDNA in BF T. brucei (12) and 47 
result in a substantial decrease of ISM sensitivity (7, 13). The mechanism of compensation 48 
is not fully understood but appears to involve uncoupling of F1 from FO and altered kinetics 49 
(11, 12). 50 
 51 
Recently, it was reported that perturbation of the vacuolar ATPase (V-ATPase) affects 52 
mitochondrial ATPase function and kDNA dependence in trypanosomes. V-ATPase is 53 
essential in T. brucei, but sub-lethal inhibition of the complex by low-efficiency RNAi or with 54 
the V-ATPase inhibitor bafilomycin A1 (BafA) permitted survival for at least 3 days in the 55 
presence of normally lethal concentrations of ISM (14). The physiological mechanism of 56 
compensation remained obscure. We decided to investigate the effects of sublethal 57 
concentrations of BafA on kDNA dependence over longer time scales. All methods were 58 
performed as described previously (7, 12) unless specified.  59 
 60 
We first investigated whether V-ATPase inhibition affects dependence of BF T. brucei on 61 
RNA editing. RNA Editing Ligase 1 (REL1) is a key component of the T. brucei editosome 62 
and its knock-down is lethal (15, 16). Expression of an ATP synthase γ subunit with an 63 
L262P mutation fully rescues from this phenotype (12). If partial inhibition of the V-ATPase 64 
by BafA renders cells impervious to kDNA loss, then treatment with the drug should also 65 
rescue from the growth phenotype observed upon knock down of REL1.  66 
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 67 
We used a REL1 conditional knock-out cell line (REL1-cKO), where an ectopic copy of the 68 
REL1 gene is under control of a tetracycline (Tet)-inducible promoter and both 69 
endogenous REL1 alleles have been deleted (15). After removal of Tet from the medium, 70 
cKO-REL1 cells exhibited a rapid and severe growth defect, with growth ceasing 71 
completely after 96 hours (Fig. 1A, dashed black curve), and no live cells being visible 72 
under the microscope at later time points, as observed before (15). The presence of 8 nM 73 
or 10 nM BafA alleviated the growth defect, with cells continuing to proliferate 168 hours 74 
after Tet removal (Fig. 1A and B, dashed cyan and blue curves and columns, respectively) 75 
despite REL1 being below the detection limit in a western blot assay (Fig. 1C and D; all 76 
image acquisitions and analyses were performed digitally with Li-Cor Odyssey or C-Digit 77 
systems). Lower concentrations of BafA did not alleviate the growth defect caused by 78 
REL1 depletion (Fig. 1A, green curves) while higher BafA concentrations caused a severe 79 
growth defect even in the presence of Tet (Fig. 1A, pink curves). We note that the range of 80 
concentrations in which rescue occurred was narrow and varied slightly between 81 
experiments and BafA stocks (data not shown). To investigate if BafA affected knockdown 82 
of RNA editing itself, we assessed levels of the F1FO ATPase subunit Tb2. The stability of 83 
this protein depends on presence of the kDNA-encoded FO subunit a: in the absence of 84 
functional kDNA (and thus subunit a), the level of Tb2 is substantially reduced (Fig. 1E and 85 
F) (17). We found that even in the presence of 8 nM or 10 nM BafA, knockdown of REL1 86 
reduced levels of Tb2 to at least the same extend as loss of kDNA (Fig. 1C). We conclude 87 
that the rescue effect provided by BafA appears to reduce dependence on a functional 88 
F1FO-ATPase, as suggested by Baker et al. (14). 89 
 90 
Next, we investigated if treatment with BafA would rescue from cell death caused by kDNA 91 
loss, induced either genetically or pharmacologically. To induce kDNA loss genetically, we 92 
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repressed expression of TAC102, an essential component of the tripartite attachment 93 
complex and thus required for kDNA segregation during cell division (18). As expected, 94 
Tet-induced TAC102 knockdown in the published RNAi cell line (18) caused a severe 95 
growth defect and kDNA loss (Fig. 2). In contrast to the RNA editing knockdown 96 
experiment, however, we did not observe any rescue of either phenotype by incubation 97 
with BafA (Fig. 2A and D).  98 
 99 
To induce kDNA loss pharmacologically, we treated BF T. brucei cells with 0.1 nM ISM. At 100 
this concentration, ISM causes kDNA loss but only a very minor growth defect in kDNA-101 
independent cells, as demonstrated by transgenic expression of an F1 subunit γ allele with 102 
the L262P mutation (Fig. 3A, green triangles and lines; see also reference (7)). In the 103 
absence of BafA, kDNA-dependent cells showed a severe growth defect: cells complete 104 
stopped proliferating after 168 hours (Fig. 3A, black squares and lines), with few, if any, 105 
surviving cells visible by microscopic inspection after 240 hours or later. In contrast, in the 106 
presence of 10 nM or 15 nM BafA cells continued to proliferate, albeit at much reduced 107 
rates (Fig. 3A, blue and orange symbols and lines). The difference in cumulative growth 108 
after 313 hours (the endpoint of the experiment) was reproducible and statistically 109 
significant (Fig. 3B). At 8 nM BafA the rescue effect was less pronounced (Fig. 3A, cyan 110 
triangles and lines, experiment terminated after 192 hours), while 20 nM BafA caused a 111 
severe growth defect even in the absence of ISM, as observed before (Fig. 3A and Fig. 112 
1A, pink circles and lines, experiment also terminated after 192 hours). In contrast to what 113 
we had found for genetic induction of kDNA loss, we observed that BafA afforded 114 
significant protection from kDNA loss caused by ISM. After 96 hours of exposure to ISM, 115 
about 70% of control cells had lost their kDNA, as observed by staining with 4',6-116 
diamidino-2-phenylindole (DAPI) and microscopy (Fig. 3C; 0K1N, cells with 1 nucleus but 117 
no kinetoplast). In cultures where we added 10 nM or 15 nM BafA to the growth medium 118 
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the fraction of 0K1N cells present at 96 hours was reduced to ~50% and ~30%, 119 
respectively (Fig. 3C). In cells where a kinetoplast was visible (1K1N cells), quantitation of 120 
kDNA by measuring relative fluorescence compared to the nucleus confirmed that 121 
exposure to ISM for 96 hours caused a significant reduction in the amount of organellar 122 
DNA, presumably an intermediate stage to complete kDNA loss (Fig. 3D). Incubation with 123 
15 nM BafA ISM provided highly significant protection from this effect (Fig. 3D). Taken 124 
together, the experiments with kDNA loss induced genetically or by ISM treatment suggest 125 
the following: pharmacological inhibition of the V-ATPase with BafA cannot protect T. 126 
brucei from the lethal effects of complete loss of kDNA. Instead, BafA reduces kDNA 127 
damage and loss caused by ISM. 128 
 129 
Finally, we induced kDNA loss with an alternative pharmacological regime, exposure to 10 130 
nM EtBr. Like ISM, EtBr is a compound from the phenanthridine class that, at low 131 
concentrations, causes kDNA loss but affects growth of kDNA-independent cells only 132 
mildly (Fig. 3E, green triangles and lines represent growth of cells expressing a γ subunit 133 
with the L262P mutation; see also references (7, 8)). We found that simultaneous 134 
incubation with 15 nM BafA resulted in a reproducible rescue from cell death caused by 135 
treatment with EtBr (Fig. 3E and F), although the effect was much less pronounced 136 
compared to ISM, and very few surviving cells were apparent after 168 hours (the endpoint 137 
of this experiment).  138 
 139 
These results pose two important questions. First, why did we observe robust rescue by 140 
BafA of growth defects caused by knockdown of RNA editing, but not of growth defects 141 
caused by inhibition of kDNA maintenance? To our present knowledge both processes 142 
serve the same goal in BF T. brucei, namely the production of F1FO subunit a (12). One 143 
potential explanation is that partial inhibition of V-ATPase makes the parasites less 144 
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dependent on proton pumping by the F1FO ATPase, for example by changing the pH 145 
balance between cellular compartments, but it does not make the parasites completely 146 
independent from it. A similar scenario has been proposed for yeast cells lacking 147 
mitochondrial DNA (19). The inducible gene expression system that we used in our study 148 
to knock down REL1 is unlikely to achieve complete repression in the absence of inducer 149 
(20), presumably resulting in some residual expression of REL1 and, consequently, 150 
subunit a. In contrast, interference with kDNA maintenance will result in an ‘all or nothing’ 151 
response in affected cells, i.e. cells that lose kDNA will completely lose subunit a and 152 
F1FO-ATPase proton pumping activity. We must note, however, that REL1 in repressed 153 
cells was below the detection limit of our western blot analysis, and FO subunit Tb2 in 154 
these cells was reduced to levels comparable to what we observe in cells depleted of 155 
kDNA. Testing this hypothesis will require development of more sensitive and highly 156 
quantitative methods for detection of intact F1FO-ATPase. Second, why was BafA more 157 
effective in rescuing the cells from the effects of ISM compared to the related EtBr? Our 158 
results provide indirect evidence that V-ATPase inhibition by BafA reduces mitochondrial 159 
uptake of ISM. How ISM and EtBr enter the mitochondrion is unknown, although efficient 160 
uptake of at least ISM appears to depend on the mitochondrial membrane potential (13). 161 
Our results suggest that the mitochondrial uptake mechanisms for ISM and EtBr may not 162 
be identical, and that V-ATPase inhibition affects uptake of ISM more than uptake of EtBr. 163 
Resolving this question will require development of methods to specifically measure 164 
mitochondrial uptake of these compounds. 165 
 166 
In summary, our results indicate complex effects of sublethal inhibition of the V-ATPase on 167 
T. brucei that affect both the degree of dependence on kDNA-encoded products as well as 168 
mitochondrial uptake of kDNA-intercalating trypanocides. Our study corroborates an 169 
intriguing link between vacuolar and mitochondrial ATPase function that begs further 170 
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investigation. Furthermore, we suggest that pharmacological inhibition of V-ATPase 171 
function can be a useful research tool in the study of otherwise lethal perturbations of 172 
mitochondrial gene expression in BF T. brucei, but it should be noted that any experiment 173 
will require careful titration of inhibitors. 174 
 175 
Acknowledgements 176 
Author contributions: C.S.-B., M. M. and A.S. designed the research, analysed the data 177 
and wrote the paper; C.S.-B., M.M. and J.S.G. performed the research. We thank David 178 
Horn (University of Dundee) for helpful discussions, Ken Stuart (Center for Infectious 179 
Disease Research) for the REL1 antibody, Alena Zikova (Biology Centre, Czech Academy 180 
of Sciences, Ceské Budejovice) for the Tb2 antibody, and Torsten Ochsenreiter (University 181 
of Bern) for the TAC102 RNAi cell line and antibody. This work was supported by Senior 182 
Non-Clinical Fellowship MR/L019701/1 from the UK Medical Research Council to A.S. and 183 
by research grant MR/K019384 from the UK Medical Research Council to Jeremy 184 
Mottram. 185 
 186 
References 187 
1.  Stuart K, Brun R, Croft S, Fairlamb A, Gürtler RE, McKerrow J, Reed S, Tarleton R. 2008. 188 
Kinetoplastids: related protozoan pathogens, different diseases. J Clin Invest 118:1301–10. 189 
2.  Morrison LJ, Vezza L, Rowan T, Hope JC. 2016. Animal African Trypanosomiasis: Time to Increase 190 
Focus on Clinically Relevant Parasite and Host Species. Trends Parasitol 32:599–607. 191 
3.  Jensen RE, Englund PT. 2012. Network news: the replication of kinetoplast DNA. Annu Rev Microbiol 192 
66:473–91. 193 
4.  Read LK, Lukeš J, Hashimi H. 2016. Trypanosome RNA editing: the complexity of getting U in and 194 
taking U out. Wiley Interdiscip Rev RNA 7:33–51. 195 
5.  Aphasizheva I, Aphasizhev R. 2016. U-Insertion/Deletion mRNA-Editing Holoenzyme: Definition in 196 
 o
n
 July 16, 2018 by UNIVERSITY O
F EDINBURG
H
http://aac.asm
.org/
D
ow
nloaded from
 
Sight. Trends Parasitol 32:144–156. 197 
6.  Giordani F, Morrison LJ, Rowan TG, DE Koning HP, Barrett MP. 2016. The animal trypanosomiases 198 
and their chemotherapy: a review. Parasitology 143:1862–1889. 199 
7.  Gould MK, Schnaufer A. 2014. Independence from kinetoplast DNA maintenance and expression is 200 
associated with multi-drug resistance in Trypanosoma brucei in vitro. Antimicrob Agents Chemother 201 
58:2925–2928. 202 
8.  Roy Chowdhury A, Bakshi R, Wang J, Yildirir G, Liu B, Pappas-Brown V, Tolun G, Griffith JD, Shapiro 203 
T a, Jensen RE, Englund PT. 2010. The killing of African trypanosomes by ethidium bromide. PLoS 204 
Pathog 6:e1001226. 205 
9.  Vercesi AE, Docampo R, Moreno SN. 1992. Energization-dependent Ca2+ accumulation in 206 
Trypanosoma brucei bloodstream and procyclic trypomastigotes mitochondria. Mol Biochem Parasitol 207 
56:251–7. 208 
10.  Nolan DP, Voorheis HP. 1992. The mitochondrion in bloodstream forms of Trypanosoma brucei is 209 
energized by the electrogenic pumping of protons catalysed by the F1F0-ATPase. Eur J Biochem 210 
209:207–16. 211 
11.  Schnaufer A, Clark-Walker GD, Steinberg AG, Stuart K. 2005. The F1-ATP synthase complex in 212 
bloodstream stage trypanosomes has an unusual and essential function. EMBO J 24:4029–40. 213 
12.  Dean S, Gould MK, Dewar CE, Schnaufer AC. 2013. Single point mutations in ATP synthase 214 
compensate for mitochondrial genome loss in trypanosomes. Proc Natl Acad Sci USA 110:14741–6. 215 
13.  Eze AA, Gould MK, Munday JC, Tagoe DNA, Stelmanis V, Schnaufer A, De Koning HP. 2016. 216 
Reduced Mitochondrial Membrane Potential Is a Late Adaptation of Trypanosoma brucei brucei to 217 
Isometamidium Preceded by Mutations in the γ Subunit of the F1Fo-ATPase. PLoS Negl Trop Dis 218 
10:e0004791. 219 
14.  Baker N, Hamilton G, Wilkes JM, Hutchinson S, Barrett MP, Horn D. 2015. Vacuolar ATPase 220 
depletion affects mitochondrial ATPase function, kinetoplast dependency, and drug sensitivity in 221 
trypanosomes. Proc Natl Acad Sci U S A 112:9112–7. 222 
15.  Schnaufer A, Panigrahi AK, Panicucci B, Igo RP, Wirtz E, Salavati R, Stuart K. 2001. An RNA ligase 223 
essential for RNA editing and survival of the bloodstream form of Trypanosoma brucei. Science (80- ) 224 
 o
n
 July 16, 2018 by UNIVERSITY O
F EDINBURG
H
http://aac.asm
.org/
D
ow
nloaded from
 
291:2159–62. 225 
16.  Huang CE, Cruz-Reyes J, Zhelonkina AG, O’Hearn S, Wirtz E, Sollner-Webb B. 2001. Roles for 226 
ligases in the RNA editing complex of Trypanosoma brucei: band IV is needed for U-deletion and 227 
RNA repair. EMBO J 20:4694–703. 228 
17.  Šubrtová K, Panicucci B, Zíková A. 2015. ATPaseTb2, a Unique Membrane-bound FoF1-ATPase 229 
Component, Is Essential in Bloodstream and Dyskinetoplastic Trypanosomes. PLoS Pathog 230 
11:e1004660. 231 
18.  Trikin R, Doiron N, Hoffmann A, Haenni B, Jakob M, Schnaufer A, Schimanski B, Zuber B, 232 
Ochsenreiter T. 2016. TAC102 Is a Novel Component of the Mitochondrial Genome Segregation 233 
Machinery in Trypanosomes. PLoS Pathog 12:e1005586. 234 
19.  Garipler G, Dunn CD. 2013. Defects associated with mitochondrial DNA damage can be mitigated by 235 
increased vacuolar pH in Saccharomyces cerevisiae. Genetics 194:285–90. 236 
20.  Wirtz E, Leal S, Ochatt C, Cross GA. 1999. A tightly regulated inducible expression system for 237 
conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei. Mol Biochem 238 
Parasitol 99:89–101. 239 
 240 
Figure legends 241 
 242 
Figure 1. (A) Cumulative growth curves of T. brucei REL1-cKO BF cells cultured in the presence (filled 243 
symbols, solid lines) and absence (open symbols, dashed lines) of 1 µg/ml tetracycline (Tet; required for 244 
expression of REL1) and at varying concentrations of BafA. Each data point is the average of at least six 245 
separate growth curves; error bars indicate SD. (B) Comparison of cumulative cell numbers (panel A) after 246 
168 hours at 0 nM (n=6), 8 nM (n=8) and 10 nM (n=6) BafA. Statistical significance of differences was 247 
assessed with the Wilcoxon rank sum test; p<0.001 (***) for -Tet 0 nM BafA vs. -Tet 8 nM BafA and vs. -Tet 248 
10 nM BafA. (C) Western blot of samples taken at 0, 8 and 10 nM BafA after 168 hours, probed with a REL1 249 
antibody. The same blot was probed with antibodies for Tb2, to assess levels of intact F1FO-ATPase complex 250 
(the asterisk indicates a cross-reacting protein), and for EF-1α (Millipore), as a loading control. (D) 251 
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Quantification of Western blot signals, taking the average of two replicates (one shown in panel C) and 252 
indicating relative protein levels under non-induced (-Tet) compared to induced (+Tet) conditions for each 253 
BafA concentration (normalized to EF-1α). (E) Western blot of samples from T. brucei BF cells expressing an 254 
ATPase subunit γ allele with the L262P mutation, taken after 3 and 7 days of culturing in the presence of 10 255 
nM EtBr to remove kDNA. Cells grown in the absence of EtBr were used as controls. The blot was probed 256 
with antibodies for F1FO-ATPase subunit Tb2 (the asterisk indicates a cross-reacting protein, see panel C) 257 
and for EF-1α as loading control. (F) Relative quantification of the Tb2 western blot signals shown in panel C 258 
(normalized to EF-1α). 259 
 260 
Figure 2. (A) Cumulative growth curves of T. brucei TAC102 RNAi BF cells cultured in the absence (filled 261 
symbols, solid lines) and presence (open symbols, dashed lines) of 1 µg/ml Tet and at varying 262 
concentrations of BafA. Each data point is the average of 2 growth curves; error bars indicate SD. (B) 263 
Western blot of samples taken at 0, 8 and 10 nM BafA after 168 hours, probed with antibodies for TAC102 264 
and EF-1α. (C) Quantification of Western blot signals, taking the average of two replicates (one shown in 265 
panel B) and indicating relative protein levels under RNAi-induced (+Tet) to non-induced (-Tet) conditions 266 
for each BafA concentration (normalized to EF-1α). (D) Loss of kDNA (0K1N cells) assessed by DAPI staining 267 
and microscopy after 168 hours of culturing. 268 
 269 
Figure 3. (A) Cumulative growth curves for T. brucei BF cells cultured in the absence (filled symbols, solid 270 
lines) and presence (open symbols, dashed lines) of 0.1 nM ISM and at varying concentrations of BafA. In 271 
parallel, a cell line expressing an ATPase subunit γ allele with the L262P mutation was also grown in the 272 
absence of presence of 0.1 nM ISM (green triangles and lines). Each data point is the average of two growth 273 
curves, error bars indicate SD. (B) Comparison of cumulative cell numbers (panel A) after 313 hours. 274 
Statistical significance of differences was assessed with the Student unpaired T-test; 0.01<p<0.05 (*) for 0 275 
nM BafA +ISM vs. 10 nM BafA +ISM; p<0.001 (***) for 0 nM BafA +ISM vs. 15 nM BafA +ISM. (C) Loss of 276 
kDNA (0K1N cells) assessed by DAPI staining and microscopy after 96 hours of culturing. Statistical 277 
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significance of differences was assessed with the Student unpaired T-test; 0.01<p<0.05 (*) for WT +ISM 0 278 
nM BafA vs. WT +ISM 10 nM BafA or vs. WT +ISM 15 nM BafA. (D) The relative amount of kDNA in 1K1N 279 
cells after 96 hours of culturing was assessed by DAPI staining and quantitation of kinetoplast vs. nucleus 280 
fluorescence intensity. Statistical significance of differences was assessed with the Mann-Whitney test; 281 
p<0.001 (***) for -ISM 0 nM BafA (n=26) vs. +ISM 0 nM Baf A (n=35); p<0.001 (***) for +ISM 0 nM BafA vs. 282 
+ISM 15 nM BafA (n=56). (E) Cumulative growth curves of T. brucei BF cells cultured in the absence (filled 283 
symbols, solid lines) and presence (open symbols, dashed lines) of 10 nM EtBr and at varying 284 
concentrations of BafA. In parallel, a cell line expressing an ATPase subunit γ allele with the L262P mutation 285 
was also grown in the absence of presence of 10 nM EtBr (green triangles and lines). Each data point is the 286 
average from four separate growth curves, error bars indicate SD. (F) Comparison of cumulative cell 287 
numbers (panel E) after 168 hours. Statistical significance of differences was assessed with the Wilcoxon 288 
rank sum test; 0.01<p<0.05 (*) for +EtBr 0 nM BafA vs. +EtBr 15 nM BafA. 289 
 290 
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Tet
Figure 1. (A) Cumulative growth curves of T. brucei REL1-cKO BF cells cultured in the presence (filled 
symbols, solid lines) and absence (open symbols, dashed lines) of 1 µg/ml tetracycline (Tet; required for 
expression of REL1) and at varying concentrations of BafA. Each data point is the average of at least six sepa-
rate growth curves; error bars indicate SD. (B) Comparison of cumulative cell numbers (panel A) after 168 
hours at 0 nM (n=6), 8 nM (n=8) and 10 nM (n=6) BafA. Statistical significance of differences was assessed 
with the Wilcoxon rank sum test; p<0.001 (***) for -Tet 0 nM BafA vs. -Tet 8 nM BafA and vs. -Tet 10 nM BafA. 
(C) Western blot of samples taken at 0, 8 and 10 nM BafA after 168 hours, probed with a REL1 antibody. The 
same blot was probed with antibodies for Tb2, to assess levels of intact F1FO-ATPase complex (the asterisk 
indicates a cross-reacting protein), and for EF-1α (Millipore), as a loading control. (D) Quantification of West-
ern blot signals, taking the average of two replicates (one shown in panel C) and indicating relative protein 
levels under non-induced (-Tet) compared to induced (+Tet) conditions for each BafA concentration (normal-
ized to EF-1α). (E) Western blot of samples from T. brucei BF cells expressing an ATPase subunit γ allele with 
the L262P mutation, taken after 3 and 7 days of culturing in the presence of 10 nM EtBr to remove kDNA. Cells 
grown in the absence of EtBr were used as controls. The blot was probed with antibodies for F1FO-ATPase 
subunit Tb2 (the asterisk indicates a cross-reacting protein, see panel C) and for EF-1α as loading control. (F) 
Relative quantification of the Tb2 western blot signals shown in panel A (normalized to EF-1α).
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Figure 2. (A) Cumulative growth curves of T. brucei TAC102 RNAi BF cells cultured in the absence (filled 
symbols, solid lines) and presence (open symbols, dashed lines) of 1 µg/ml Tet and at varying concentrations 
of BafA. Each data point is the average of 2 growth curves; error bars indicate SD. (B) Western blot of samples 
taken at 0, 8 and 10 nM BafA after 168 hours, probed with antibodies for TAC102 and EF-1α. (C) Quantification 
of Western blot signals, taking the average of two replicates (one shown in panel B) and indicating relative 
protein levels under RNAi-induced (+Tet) to non-induced (-Tet) conditions for each BafA concentration (normal-
ized to EF-1α). (D) Loss of kDNA (0K1N cells) assessed by DAPI staining and microscopy after 168 hours of 
culturing.
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Figure 3. (A) Cumulative growth curves for T. brucei BF cells cultured in the absence (filled symbols, solid 
lines) and presence (open symbols, dashed lines) of 0.1 nM ISM and at varying concentrations of BafA. In 
parallel, a cell line expressing an ATPase subunit γ allele with the L262P mutation was also grown in the 
absence of presence of 0.1 nM ISM (green triangles and lines). Each data point is the average of two growth 
curves, error bars indicate SD. (B) Comparison of cumulative cell numbers (panel A) after 313 hours. 
Statistical significance of differences was assessed with the Student unpaired T-test; 0.01<p<0.05 (*) for 0 nM 
BafA +ISM vs. 10 nM BafA +ISM; p<0.001 (***) for 0 nM BafA +ISM vs. 15 nM BafA +ISM. (C) Loss of kDNA 
(0K1N cells) assessed by DAPI staining and microscopy after 96 hours of culturing. Statistical significance of 
differences was assessed with the Student unpaired T-test; 0.01<p<0.05 (*) for WT +ISM 0 nM BafA vs. WT 
+ISM 10 nM BafA or vs. WT +ISM 15 nM BafA. (D) The relative amount of kDNA in 1K1N cells after 96 hours 
of culturing was assessed by DAPI staining and quantitation of kinetoplast vs. nucleus fluorescence intensity. 
Statistical significance of differences was assessed with the Mann-Whitney test; p<0.001 (***) for -ISM 0 nM 
BafA (n=26) vs. +ISM 0 nM Baf A (n=35); p<0.001 (***) for +ISM 0 nM BafA vs. +ISM 15 nM BafA (n=56). 
A B
C D
E
ISM
BafA (nM)
+ + +- -
0 10 15
-
0
+-
gamma WT WT WTL262P
*
*
F
***
***
BafA (nM)
ISM + +-
0 150
Figure 3. (continued)
(E) Cumulative growth curves of T. brucei BF cells cultured in the absence (filled symbols, solid lines) and 
presence (open symbols, dashed lines) of 10 nM EtBr and at varying concentrations of BafA. In parallel, a cell 
line expressing an ATPase subunit γ allele with the L262P mutation was also grown in the absence of presence 
of 10 nM EtBr (green triangles and lines). Each data point is the average from four separate growth curves, 
error bars indicate SD. (F) Comparison of cumulative cell numbers (panel E) after 168 hours. Statistical 
significance of differences was assessed with the Wilcoxon rank sum test; 0.01<p<0.05 (*) for +EtBr 0 nM BafA 
vs. +EtBr 15 nM BafA. 
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